CollPlant Biotechnologies (CLGN) Other Accumulated Expenses (2018 - 2025)
CollPlant Biotechnologies (CLGN) posted Other Accumulated Expenses of $62000.0 for Q4 2025, down 38.61% on a QoQ basis from $101000.0 in Q4 2024, and down 38.61% year-over-year from $101000.0 in Q4 2024.
CollPlant Biotechnologies (CLGN) Other Accumulated Expenses (2018 - 2025) Analysis & Trends
CollPlant Biotechnologies' Other Accumulated Expenses history runs 6 years deep, the most recent figure standing at $62000.0 for Q4 2025.
- Quarterly Other Accumulated Expenses fell 38.61% year-over-year to $62000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $62000.0 (down 38.61% YoY) and the FY2025 annual result came in at $62000.0, down 38.61% from the prior year.
- Other Accumulated Expenses was $62000.0 for Q4 2025 at CollPlant Biotechnologies, down from $101000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $105000.0 in Q4 2023 and bottomed at $53000.0 in Q4 2022.
- A 4-year average of $80250.0 and a median of $81500.0 in 2024 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2023 — Other Accumulated Expenses jumped 98.11% — and 2025, when it sank 38.61%.
- CollPlant Biotechnologies' Other Accumulated Expenses stood at $53000.0 in 2022, then soared by 98.11% to $105000.0 in 2023, then declined by 3.81% to $101000.0 in 2024, then sank by 38.61% to $62000.0 in 2025.
- Business Quant data shows CLGN's Other Accumulated Expenses at $62000.0 in Q4 2025, $101000.0 in Q4 2024, and $105000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 62,000.00 |
| Dec 31, 2024 | 101,000.00 |
| Dec 31, 2023 | 105,000.00 |
| Dec 31, 2022 | 53,000.00 |
| Sep 30, 2019 | 323,000.00 |
| Jun 30, 2019 | 294,000.00 |
| Mar 31, 2019 | 493,000.00 |
| Dec 31, 2018 | 334,000.00 |
| Sep 30, 2018 | 518,000.00 |
| Jun 30, 2018 | 587,000.00 |
| Mar 31, 2018 | 1.95 Mn |